epigallocatechin gallate has been researched along with micafungin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
| Buer, J; Dittmer, S; Haase, G; Kirchhoff, L; Olsowski, M; Rath, PM; Sedlacek, L; Steinmann, E; Steinmann, J; Zilmans, K | 1 |
2 other study(ies) available for epigallocatechin gallate and micafungin
| Article | Year |
|---|---|
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Topics: Antifungal Agents; Bacterial Adhesion; beta-Glucans; Biofilms; Catechin; Colistin; Cystic Fibrosis; Echinocandins; Exophiala; Farnesol; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Voriconazole | 2017 |